Colirio Ocusan (DLC Laboratories, Inc.)


Welcome to the PulseAid listing for the Colirio Ocusan drug offered from DLC Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: DLC Laboratories, Inc.
NON-PROPRIETARY NAME: Polyethlene glycol 400 Tetrahydrozoline HCl
SUBSTANCE NAME: POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: OPHTHALMIC
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2011-08-31
END MARKETING DATE: 0000-00-00


Colirio Ocusan HUMAN OTC DRUG Details:

Item DescriptionColirio Ocusan from DLC Laboratories, Inc.
LABELER NAME: DLC Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10; .5(mg/mL; mg/mL)
START MARKETING DATE: 2011-08-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24286-5191_7374d2b2-bd66-4f23-95bb-4d7e6a3cf71f
PRODUCT NDC: 24286-5191
APPLICATION NUMBER: part349

Other POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
DLC Laboratories, Inc.Colirio Ocusan
Samchundang Pharm. Co., Ltd.Colirio Ocusan